[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bristol-Myers Squibbs Eliquis for the purpose of patent e...[ Price : $8.95]
An FDA advisory committee votes 11 to 3 to recommend approval of a Teva Pharmaceutical Industries BLA for Cinqair (reslizumab) for...[ Price : $8.95]
Johns Hopkins Bloomberg School of Public Health professor Gerard Anderson tells a Senate hearing that Congress should consider cre...[ Price : $8.95]
An FDA-funded study demonstrates that consumers gain a better understanding of drug safety risk communications when they follow pl...[ Price : $8.95]
FDA staffers describe the process the agency followed in first rejecting and then approving Sprouts flibanserin for treating femal...[ Price : $8.95]
CDRH Office of Compliance (OC) acting director Sean Boyd says OC has several initiatives under way to shift the way it monitors or...[ Price : $8.95]
Federal Register Notice: FDA withdraws approval of two NADAs/ANADAs that are no longer marketed.[ Price : $8.95]
FDA approves a Medtronic PMA to allow full-body magnetic resonance imaging (MRI) procedures for patients using Activa Deep Brain S...